OAR 333-007-0340
Compliance Testing Requirements for Cannabinoid Products


(1) A processor or processing site must test every process lot of a finished cannabinoid product intended for human consumption, use or ingestion for use by a consumer or patient prior to selling or transferring the cannabinoid product for THC and CBD concentration in accordance with OAR 333-007-0430 (Standards for THC and CBD Compliance Testing).
(2) A processor or processing site must test a process lot of a finished cannabinoid product intended for human consumption, use or ingestion for microbiological contaminants in accordance with OAR 333-007-0390 (Standards for Microbiological Contaminants Compliance Testing), upon written request by the Authority or the Commission.
(3) In lieu of ordering and arranging for the sampling and testing required in this rule a processor may transport batches of cannabinoid products referenced in section (1) of this rule to a wholesaler licensed by the Commission under ORS 475B.100 (Wholesale license) and the wholesaler may order and arrange for the sampling and testing of the batches, in accordance with rules established by the Commission.

Source: Rule 333-007-0340 — Compliance Testing Requirements for Cannabinoid Products, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=333-007-0340.

Last Updated

Jun. 8, 2021

Rule 333-007-0340’s source at or​.us